CRSP Stock On Wild Ride After FDA's Historic Approval. These Gene Editing Treatments Could Be Next.
51:13
CRISPR 2.0, the Next Generation
55:39
Stanford Webinar - CRISPR - 10 Years of Genome Editing and More
55:03
The Insider's Edge To Real Estate Investing with Adam Wolfson
13:55
Microsoft Leans On AI To Reinvent Its Leadership Role | Growth Stories | Alexis Garcia
1:00:12
The Future of Medicine: CRISPR, Drug Prices & Gene Therapy
1:02:23
Multiscale Computational Microscopy for Drug and Immunogen Design
36:57
The Arcturus Therapeutics Story, mRNA and The Search for Transformative Medicines
14:45